Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aryl Boronic Acid Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111217847B reveals novel thiosilane ligands enabling high-yield aryl boronation with superior purification and industrial scalability for pharma intermediates.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN111217847A discloses stable thiosilane ligands for iridium-catalyzed borylation, offering superior yield and simplified purification for reliable pharmaceutical intermediate suppliers.
Patent CN111217847B introduces efficient thiosilane ligands for aryl boronation, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Solve low yield and purification challenges in arylboronic acid synthesis. Our CDMO expertise scales thiosilane ligand technology for 99% purity and cost efficiency.
Discover how thiosilane ligands enable high-yield aryl boronic acid synthesis with easy purification, reducing costs and supply chain risks for pharmaceutical intermediates.